Sagimet Biosciences (SGMT) Non-Current Assets (2022 - 2026)

Sagimet Biosciences (SGMT) recorded quarterly Non-Current Assets of $39000.0 in Q1 2026, down 50.0% quarter-over-quarter from $78000.0 in Q4 2025, and down 61.0% on a YoY basis from $100000.0 in Q1 2025.

Sagimet Biosciences (SGMT) Non-Current Assets (2022 - 2026) Analysis & Trends

Sagimet Biosciences' Non-Current Assets history runs 5 years deep, the most recent figure standing at $39000.0 for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 61.0% year-over-year to $39000.0; the TTM figure through Mar 2026 stood at $19.2 million (down 59.42% YoY), while the FY2025 annual figure was $78000.0, down 98.96% from the prior year.
  • Non-Current Assets was $39000.0 for Q1 2026 at Sagimet Biosciences, down from $78000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $22.3 million in Q2 2024 to a low of $37000.0 in Q1 2024.
  • Historically, Non-Current Assets has averaged $5.2 million across 5 years, with a median of $144000.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets jumped 16033.03% in 2024, then sank 98.96% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $239000.0 in 2022, then slumped by 69.46% to $73000.0 in 2023, then jumped by 10153.42% to $7.5 million in 2024, then tumbled by 98.96% to $78000.0 in 2025, then tumbled by 50.0% to $39000.0 in 2026.
  • The last three Non-Current Assets figures came in at $39000.0 (Q1 2026), $78000.0 (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 62,953.78
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4.56 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 30.30 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.71 Bn 91.71 Bn - 39.71 Mn
10 Sagimet Biosciences 211.96 Mn 211.96 Mn - 39,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 39,000.00
Dec 31, 2025 78,000.00
Sep 30, 2025 8.92 Mn
Jun 30, 2025 10.21 Mn
Mar 31, 2025 100,000.00
Dec 31, 2024 7.49 Mn
Sep 30, 2024 17.59 Mn
Jun 30, 2024 22.27 Mn
Mar 31, 2024 37,000.00
Dec 31, 2023 73,000.00
Sep 30, 2023 109,000.00
Jun 30, 2023 144,000.00
Dec 31, 2022 239,000.00